Mr. Chair, in response, this is an area where we were taking action prior to the report, and have done so subsequently. We think it is critically important that the products are not only reviewed by Health Canada's commissioner...tested in a report, and that the pre-market review of safety and efficacy is done well and appropriately, but also that while they're on the market, it be ensured that Canadians accessing them can feel comfortable that they are safe, effective and of high quality.
We have gazetted, in the spring of 2021, labelling regulations to improve the quality and readability of information required, including dosage and warning information. Those will be finalized this spring. We have moved to proactive monitoring of advertising, including online, both for COVID products and, as I'd mentioned, for NHPs with cancer-related claims. We are going to be broadening this. We're taking steps to strengthen our ability to do this as well through increased resources by bringing in cost recovery from manufacturers and licence-holders for natural health products to strengthen our ability to provide this post-market oversight.